14,000-Person study hunts for hidden triggers of rare tumors
NCT ID NCT06282016
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to find out what factors might increase the risk of developing neuroendocrine tumors, a rare type of cancer. Researchers will analyze health records from over 14,000 people in Bavaria, Germany, looking at things like smoking, diabetes, and even depression. The goal is to better understand why these tumors have become more common in recent years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROENDOCRINE NEOPLASM OF LUNG are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Bavarian Cancer Registry, Bavarian Health and Food Safety Authority
RECRUITINGNuremberg, Bavaria, 90441, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••